Immunotherapy in Small Cell Lung Cancer

Immunotherapy in Small Cell Lung Cancer

Small-cell lung cancer (SCLC) is an aggressive tumor type with limited therapeutic options and poor prognosis. Chemotherapy regimens containing platinum represent the cornerstone of treatment for patients with extensive disease, but there has been no real progress for 30 years. The evidence that SCL...

Full description

Bibliographic Details
Main Authors: Giovanna Esposito, Giuliano Palumbo, Guido Carillio, Anna Manzo, Agnese Montanino, Vincenzo Sforza, Raffaele Costanzo, Claudia Sandomenico, Carmine La Manna, Nicola Martucci, Antonello La Rocca, Giuseppe De Luca, Maria Carmela Piccirillo, Rossella De Cecio, Gerardo Botti, Giuseppe Totaro, Paolo Muto, Carmine Picone, Nicola Normanno, Alessandro Morabito
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Cancers
Subjects:
SCLC
ipilimumab
tremelimumab
nivolumab
atezolizumab
pembrolizumab
Online Access:https://www.mdpi.com/2072-6694/12/9/2522

Internet

https://www.mdpi.com/2072-6694/12/9/2522

Similar Items